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Background:  Distal protection and thrombus aspiration (DP-TA) has not improved microvascular circulation nor decreased myocardial injury 
during primary percutaneous coroanry intervention (PCI) for ST-segment elevation myocardial infarction (STEMI). In a prospective randomized trial, 
we investigated the mechanism of the poor effect of DP-TA in patients with STEMI.
Methods:  Patients with STEMI were randomly assigned to DP-TA pretreatment or conventional PCI (c-PCI). End points were infarct ratio (infarct size 
to entire LV size) by delayed enhancement (DE), area at risk (AAR) ratio (AAR to entire LV size) by T2 weighted image, microvascular occlusion index 
(MVO) ratio (MVO to entire LV size) by DE, and myocardial salvage index (MSI: infarct size x 100/AAR) using cardiac MR within 3 days after PCI. 
Secondary end points were post-PCI peak CK-MB, ejection fraction (EF) and remodeling index (RI) measured by cardiac MR at 6 month.
Results:  Infarct ratio, AAR ratio and MSI were not statistically different between DP-TA group and c-PCI group (see table). MVO ratio, however, were 
significantly larger in DP-TA group than c-PCI group (p=0.045). Mean peak CK-MB and 6-month EF were not different whereas RI was larger in DT-PA 
group with borderline significance (p=0.054). In subgroup analyses, infarct territory or lesion proximity did not affect the results.
Conclusions:  DP-TA was potentially hazardous in primary PCI for STEMI by increasing MVO. Therefore, use of DP-TA should be limited in STEMI.
End points (mean±standard deviation)
DT-PA (n=41) c-PCI (n=43) significance
Infarct ratio (%) 34.7±13.6 35.7±14.6 0.770
AAR ratio (%) 50.0±14.1 46.1±16.4 0.296
MSI (%) 31.6±18.8 27.6±20.8 0.403
MVO ratio (%) 2.4±2.7 1.1±1.9 0.045
Peak CK-MB (IU/mL) 398±37 424±35.7 0.618
EF at 6 month 59.5±12.9 60.7±14.7 0.695
RI 8.8±3.8 -0.3±2.7 0.054
